188 related articles for article (PubMed ID: 6214431)
21. [Treatment of endometriosis with domestic luteinizing hormone--releasing hormone analogue].
Geng L; Gu FY; Zhang LZ
Zhonghua Fu Chan Ke Za Zhi; 1994 Oct; 29(10):592-4, 636. PubMed ID: 7712871
[TBL] [Abstract][Full Text] [Related]
22. Levels of luteinizing hormone (LH), follicle-stimulating hormone, and 17 beta-estradiol in response to D-Trp6-LH-releasing hormone during different phases of the menstrual cycle in normal women.
Jaramillo CJ; Salgado AC; Perez-Infante V; Puente-Cueva M; Botella-Llusia J; Coy DH; Schally A
Fertil Steril; 1978 Feb; 29(2):153-8. PubMed ID: 342285
[TBL] [Abstract][Full Text] [Related]
23. Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin).
Schriock E; Monroe SE; Henzl M; Jaffe RB
Fertil Steril; 1985 Nov; 44(5):583-8. PubMed ID: 2932349
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic hypogonadism induced by a delayed-release preparation of microcapsules of D-Trp-6-luteinizing hormone-releasing hormone: a preliminary study in eight women with endometriosis.
Zorn JR; Tanger C; Roger M; Grenier J; Comaru-Schally AM; Schally AV
Int J Fertil; 1986; 31(1):11-3, 16-27. PubMed ID: 2908272
[TBL] [Abstract][Full Text] [Related]
25. Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis.
Kettel LM; Murphy AA; Mortola JF; Liu JH; Ulmann A; Yen SS
Fertil Steril; 1991 Sep; 56(3):402-7. PubMed ID: 1716596
[TBL] [Abstract][Full Text] [Related]
26. Prevention of follicular maturation in endometriosis by subcutaneous infusion of luteinizing hormone-releasing hormone agonist started in the luteal phase.
Lemay A; Sandow J; Bureau M; Maheux R; Fontaine JY; Mérat P
Fertil Steril; 1988 Mar; 49(3):410-7. PubMed ID: 3125068
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of ovulation in women by chronic treatment with a stimulatory LRH analogue--a new approach to birth control?
Nillius SJ; Bergquist C; Wide L
Contraception; 1978 Jun; 17(6):537-45. PubMed ID: 352612
[TBL] [Abstract][Full Text] [Related]
28. [Effect of the steroid sex hormones on the LH and FSH responses to LHRH in the normal subject].
Lemarchand-Béraud T; Reymond M; Rappoport G; Magrini G; Gomez J
Pathol Biol (Paris); 1975 Dec; 23(10):917-22. PubMed ID: 772543
[TBL] [Abstract][Full Text] [Related]
29. A prospective randomized study comparing endocrinological and clinical effects of two types of GnRH agonists in cases of uterine leiomyomas or endometriosis.
Takeuchi H; Kobori H; Kikuchi I; Sato Y; Mitsuhashi N
J Obstet Gynaecol Res; 2000 Oct; 26(5):325-31. PubMed ID: 11147718
[TBL] [Abstract][Full Text] [Related]
30. Treatment of endometriosis in monkeys: effectiveness of continuous infusion of a gonadotropin-releasing hormone agonist compared to treatment with a progestational steroid.
Mann DR; Collins DC; Smith MM; Kessler MJ; Gould KG
J Clin Endocrinol Metab; 1986 Dec; 63(6):1277-83. PubMed ID: 3097054
[TBL] [Abstract][Full Text] [Related]
31. [Successful treatment of endometriosis in women with continuous subcutaneous infusion of gonadotropin-releasing hormone agonist (GnRH-A)].
Masaoka K; Kitazawa M; Kumasaka T
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Apr; 41(4):405-11. PubMed ID: 2501437
[TBL] [Abstract][Full Text] [Related]
32. Endometrial histology during intermittent intranasal luteinizing hormone-releasing hormone (LH-RH) agonist sequentially combined with an oral progestogen as an antiovulatory contraceptive approach.
Lemay A; Jean C; Faure N
Fertil Steril; 1987 Nov; 48(5):775-82. PubMed ID: 2959569
[TBL] [Abstract][Full Text] [Related]
33. Treatment of endometriosis with a delayed release preparation of the agonist D-Trp6-luteinizing hormone-releasing hormone: long-term follow-up in a series of 50 patients.
Zorn JR; Mathieson J; Risquez F; Comaru-Schally AM; Schally AV
Fertil Steril; 1990 Mar; 53(3):401-6. PubMed ID: 2137792
[TBL] [Abstract][Full Text] [Related]
34. Effects of aging on the hypothalamic-hypophyseal-gonadal axis in female rats.
McPherson JC; Costoff A; Mahesh VB
Fertil Steril; 1977 Dec; 28(12):1365-70. PubMed ID: 201506
[TBL] [Abstract][Full Text] [Related]
35. Luteinizing hormone releasing hormone agonist for contraception in breast feeding women.
Fraser HM; Dewart PJ; Smith SK; Cowen GM; Sandow J; McNeilly AS
J Clin Endocrinol Metab; 1989 Nov; 69(5):996-1002. PubMed ID: 2507572
[TBL] [Abstract][Full Text] [Related]
36. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult men.
Faure N; Labrie F; Lemay A; Bélanger A; Gourdeau Y; Laroche B; Robert G
Fertil Steril; 1982 Mar; 37(3):416-24. PubMed ID: 6800852
[TBL] [Abstract][Full Text] [Related]
38. Sustained gonadal suppression in fertile women with the LHRH agonist buserelin.
Hardt W; Schmidt-Gollwitzer M
Clin Endocrinol (Oxf); 1983 Nov; 19(5):613-7. PubMed ID: 6416718
[TBL] [Abstract][Full Text] [Related]
39. Luteinizing hormone-releasing hormone (LH-RH) as a diagnostic and research tool in gynecologic endocrinology.
Taymor ML; Thompson IE; Berger MJ; Patton W
Am J Obstet Gynecol; 1974 Nov; 120(6):721-32. PubMed ID: 4611213
[TBL] [Abstract][Full Text] [Related]
40. Chronic effects of the stimulatory luteinizing hormone-releasing hormone analogue D-Ser (TBU) 6-EA 10-LRH on the gonadotrophin and gonadal steroid secretion in women with amenorrhoea.
Skarin G; Nillius SJ; Wide L
Ups J Med Sci; 1980; 85(2):103-12. PubMed ID: 6787767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]